Head-To-Head Comparison: Gadsden Properties (OTCMKTS:GADS) vs. Vivani Medical (NASDAQ:VANI)

Vivani Medical (NASDAQ:VANI) and Gadsden Properties (OTCMKTS:GADS) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, institutional ownership, earnings, profitability and dividends.

Insider & Institutional Ownership

6.8% of Vivani Medical shares are owned by institutional investors. 44.3% of Vivani Medical shares are owned by company insiders. Comparatively, 5.0% of Gadsden Properties shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares Vivani Medical and Gadsden Properties’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Vivani Medical	N/A	-102.42%	-49.21%
Gadsden Properties	N/A	N/A	N/A

Risk & Volatility

Vivani Medical has a beta of 3.22, indicating that its share price is 222% more volatile than the S&P 500. Comparatively, Gadsden Properties has a beta of -5.57, indicating that its share price is 657% less volatile than the S&P 500.

Analyst Recommendations

This is a summary of current recommendations and price targets for Vivani Medical and Gadsden Properties, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vivani Medical	0	0	1	0	3.00
Gadsden Properties	0	0	0	0	0.00

Vivani Medical presently has a consensus target price of $3.00, indicating a potential upside of 160.87%. Given Vivani Medical’s stronger consensus rating and higher probable upside, analysts plainly believe Vivani Medical is more favorable than Gadsden Properties.

Valuation & Earnings

This table compares Vivani Medical and Gadsden Properties”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vivani Medical	N/A	N/A	-$25.65 million	($0.45)	-2.56
Gadsden Properties	N/A	N/A	N/A	N/A	N/A

Summary

Vivani Medical beats Gadsden Properties on 6 of the 8 factors compared between the two stocks.

About Vivani Medical

Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.

About Gadsden Properties

Gadsden Properties, Inc. is a Nevada corporation that was formed on December 28, 2010. Gadsden concentrates primarily on investments in high quality income-producing assets, residential developments and other opportunistic commercial properties in secondary and tertiary markets across the United States. The Company derives value from smaller, flexible retail investments that range from $5 million to $50 million and off-market mixed-use properties ranging from $50 million to $250 million. As a result of this chosen strategy, we believe that Gadsden is developing a unique competitive advantage that generally allows the Company to invest in markets and assets that are often overlooked by larger institutional investors, such as publicly-traded REITs and other large institutional investors. As part of its strategy, Gadsden attracts specific sellers that prefer the tax deferral advantages offered through issuing operating partnership units in exchange for their properties. These real estate assets are typically operated by independent owners that are seeking to monetize their real estate holdings, and who are typically not well capitalized or well-seasoned real estate operators. These transactions create a variety of outcomes for Gadsden and the sellers typically resulting in lease-up and value-added opportunities that may not be otherwise achieved.